Due to a shortage of U.S.-approved Panretin gel (alitretinoin 0.1%; Eisai), the Food and Drug Administration (FDA) has announced they are allowing the sale of the E.U.-approved version of the gel, accompanied with a copy of the U.S.-approved prescribing information.
Overall rates of cancer and cancer mortality in the United States continue to decline, according to the Annual Report to the Nation on the Status of Cancer.
In a study of more than 1.1 million cancer patients who had surgery, Harvard researchers found that almost 5% died within one month of their operation.
About 14.5 million U.S. cancer survivors are alive today, compared to just three million in 1971, with prevention and targeted therapies helping to reduce mortality.
A medical practice in KY has pleaded guilty to federal charges regarding the purchasing and selling of unapproved and improperly labeled chemotherapy drugs.
The risk for certain types of cancer seems to be linked to poverty or wealth and socioeconomic status should be considered in cancer surveillance.
For patients undergoing radiotherapy, shared decision-making and patient-perceived control in treatment decisions correlate with increased patient satisfaction.
By age 50 years, more than half of childhood cancer survivors have experienced a severe, disabling, life-threatening, or fatal health condition.
About one-third of U.S. oncologists report being satisfied with work-life balance (WLB), which is lower than for other medical specialties.
Experts have identified three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging, and drug pricing.
Terminally ill patients with cancer who receive chemotherapy at the end of life are at increased risk of dying in an ICU and receiving CPR and/or mechanical ventilation.
The USPSTF has found that insufficient evidence to evaluate the benefits and harms of multivitamins and most single- or paired-nutrient supplements for the prevention of cardiovascular disease and cancer.
Recommendations relating to the key elements of minimum adequate cancer family history are detailed, although they are often incompletely implemented.
Sun Pharma announced that it has sufficient supplies of Doxorubicin HCl Liposome Injection to cover the U.S. market as Janssen's Doxil ends production.
Although significant progress has been made in treating cancer, >1.6 million Americans are projected to receive a cancer diagnosis in 2013.
Fewer Medicare beneficiaries are dying in the setting of acute care hospitals, but health care transitions and intensive care unit (ICU) utilization are increasing in the last month of life.
The FDA announced that it has approved Doxorubicin HCl Liposome Injection, the first generic version of Janssen Biotech's Doxil.
Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer and neutropenia who are at low risk of complications.